{"database": "lobbying", "table": "lobbying_activities", "rows": [[2508429, "29e2e46e-0b2f-4ad8-b689-ad92576c9ded", "Q3", "ROCK & ASSOCIATES", 33545, "BRAIDWOOD MANAGEMENT, INC.", 2020, "third_quarter", "PHA", "H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 11250, null, 0, 0, "2020-10-14T23:46:39.977000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2508429"], "units": {}, "query_ms": 0.3767781890928745, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}